The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers

The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers

Head and neck cancer (HNC) is the sixth most common cancer type, accounting for approximately 277,597 deaths worldwide. Recently, the Food and Drug Administration (FDA) has approved immune checkpoint blockade (ICB) agents targeting programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) as a...

Full description

Bibliographic Details
Main Authors: Sarra Mestiri, Dina Moustafa Abo El-Ella, Queenie Fernandes, Takwa Bedhiafi, Salam Almoghrabi, Shayista Akbar, Varghese Inchakalody, Laila Assami, Shaheena Anwar, Shahab Uddin, Abdul Rehman Zar Gul, Mariam Al-Muftah, Maysaloun Merhi, Afsheen Raza, Said Dermime
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Head and neck cancer
Immune checkpoint molecules
Stimulatory and inhibitory biomarkers
Diagnosis
And prognosis biomarkers
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223018930

Similar Items

Similar Items